Search results for "EXPOSURE"

showing 10 items of 1125 documents

Biomarker responses of the earthworm Aporrectodea tuberculata to copper and zinc exposure: differences between populations with and without earlier m…

2003

Biomarkers in the earthworm Aporrectodea tuberculata (Eisen) were measured to find out their possible induction under Cu and Zn exposure and differences in the responses between two populations with different exposure history. The biomarkers applied were concentration of metallothioneins (MT), and cytochrome P4501A (CYP1A) monooxygenase and glutathione-S-transferase (GST) activities. These were measured from earthworms sampled at three distances from a steel smelter in Finland and from the individuals from two populations, one with and another without earlier metal exposure, exposed to three combined Cu/Zn concentrations in the laboratory. In the field, MT concentration, and cytochrome CYP1…

Cytoplasmfood.ingredientHealth Toxicology and MutagenesisPopulationToxicologymedicine.disease_causefoodbiology.animalMicrosomesmedicineLumbricidaeMetallothioneinAnimalsSoil PollutantsOligochaetaeducationGlutathione Transferaseeducation.field_of_studybiologyEarthwormCopper toxicityGeneral MedicineEnvironmental exposureEnvironmental Exposurebiology.organism_classificationmedicine.diseasePollutionZincSteelEnvironmental chemistryZinc toxicityAporrectodeaMetallothioneinAryl Hydrocarbon HydroxylasesBiomarkersCopperEnvironmental MonitoringEnvironmental pollution (Barking, Essex : 1987)
researchProduct

In vivo ozone exposure does not increase DNA single-strand breaks in human peripheral lymphocytes

2013

In this randomized parallel study, we examined whether an acute ozone (O3) exposure leads to increased DNA strand breaks in human lymphocytes. The groups were exposed to 0.21 ppm O3 or filtered air for two hours. 30min and 4.5 h after exposure, DNA damage was determined in isolated lymphocytes using the Fast Micromethod. There was no detectable effect after O3 exposure. We conclude that an acute O3 exposure at the tested concentration does not lead to persistent DNA damage.

DNA single strandOzoneDNA damageHealth Toxicology and MutagenesisDNA Single-StrandedParallel studyGeneral MedicineBiologyToxicologyMolecular biologyPeripheralchemistry.chemical_compoundOzonechemistryIn vivoImmunologyHumansLymphocytesOzone exposureDNADNA DamageHuman & Experimental Toxicology
researchProduct

Overdiagnosis and overimaging: an ethical issue for radiological protection

2019

Aims and objectives: This study aimed to analyse the key factors that influence the overimaging using X-ray such as self-referral, defensive medicine and duplicate imaging studies and to emphasize the ethical problem that derives from it. Materials and methods: In this study, we focused on the more frequent sources of overdiagnosis such as the total-body CT, proposed in the form of screening in both public and private sector, the choice of the most sensitive test for each pathology such as pulmonary embolism, ultrasound investigations mostly of the thyroid and of the prostate and MR examinations, especially of the musculoskeletal system. Results: The direct follow of overdiagnosis and overi…

Defensive MedicineMalemedicine.medical_specialtyThyroid GlandContrast MediaMedical OveruseoverdiagnosisSensitivity and Specificity030218 nuclear medicine & medical imagingDefensive medicine03 medical and health sciences0302 clinical medicinemedicineHumansWhole Body ImagingRadiology Nuclear Medicine and imagingBioethical IssuesEthicOverdiagnosisIntensive care medicineNeuroradiologyRadiation protectionethics; overdiagnosis; overimaging; radiation protectionmedicine.diagnostic_testOverimagingbusiness.industryProstatePhysician Self-ReferralInterventional radiologyGeneral MedicineRadiation ExposurePrivate sectorethicsMagnetic Resonance ImagingTest (assessment)Key factorsOverdiagnosi030220 oncology & carcinogenesisRadiological weaponRadiologybusinessLa radiologia medica
researchProduct

Comparative evaluation of liquid chromatography versus gas chromatography using a β-cyclodextrin stationary phase for the determination of BTEX in oc…

2009

An HPLC method for the determination of benzene, toluene, ethylbenzene and o-xylene, m-xylene and p-xylene in occupational environments was developed and compared with a GC-MS method. Chromatographic analysis using a beta-cyclodextrin stationary phase was performed after active and passive air sampling by adsorption on activated charcoal and pressurized fluid extraction. The analytes were completely separated and quantified using both methods, although GC-MS provided better resolutions and lower detection limits than HPLC. The HPLC method was unsuccessfully applied to the determination of benzene in real samples because its sensitivity was too low. Both methods were applied to the analysis …

Detection limitChromatography GasChromatographybeta-CyclodextrinsAnalytical chemistryBenzeneBeta-CyclodextrinsBTEXXylenesHigh-performance liquid chromatographyEthylbenzeneAnalytical Chemistrychemistry.chemical_compoundCertified reference materialschemistryOccupational ExposureBenzene DerivativesGas chromatographyGas chromatography–mass spectrometryChromatography LiquidTolueneTalanta
researchProduct

Estimation of the presence of unmetabolized dialkyl phthalates in untreated human urine by an on-line miniaturized reliable method

2015

Abstract At present, human exposure to dialkyl phthalates is assessed through urinary measurement of their metabolites due mainly to contamination in their analysis by their ubiquitous presence. An on-line miniaturized method and the processing of the untreated urine samples have been the key factors for minimizing contamination and achieving unbiased results. Di(2-ethylhexyl) (DEHP), diethyl (DEP), dibutyl (DBP) and mono-ethylhexyl (MEHP) phthalates in urine samples have been included in the study; MEHP as metabolite of the main dialkyl phthalate such as DEHP. On-line in-tube solid-phase microextraction (IT-SPME)-capillary liquid chromatography (CapLC) with diode array detection (DAD) is e…

Detection limitendocrine systemEnvironmental EngineeringChromatographyMetabolitePhthalic AcidsPhthalateEnvironmental ExposureUrineUrinalysisContaminationPollutionDiode arraychemistry.chemical_compoundKey factorschemistryHuman exposureHumansEnvironmental ChemistryEnvironmental PollutantsWaste Management and DisposalScience of The Total Environment
researchProduct

Human risk assessment and regulatory framework for minerals in food

2015

Dietary exposureEnvironmental healthEnvironmental scienceLegislationRisk assessment
researchProduct

Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes.

2017

Azole-resistant Aspergillus fumigatus (ARAF) has been reported in patients with chronic obstructive pulmonary disease (COPD) but has not been specifically assessed so far. Here, we evaluated ARAF prevalence in azole-naïve COPD patients and their homes, and assessed whether CYP51A mutations were similar in clinical and environmental reservoirs. Sixty respiratory samples from 41 COPD patients with acute exacerbation and environmental samples from 36 of these patient's homes were prospectively collected. A. fumigatus was detected in respiratory samples from 11 of 41 patients (27%) and in 15 of 36 domiciles (42%). Cyp51A sequencing and selection on itraconazole medium of clinical (n = 68) and e…

Drug Resistance Fungal -- genetics0301 basic medicineAzolesMaleAntifungal AgentsExacerbationMESH: Fungal Proteins/isolation & purification[SDV]Life Sciences [q-bio]Colony Count MicrobialAspergillus fumigatusMESH: Aspergillus fumigatus/drug effectsMESH: Cytochrome P-450 Enzyme System/drug effectsMESH: GenotypePulmonary Disease Chronic ObstructivedwellingCytochrome P-450 Enzyme SystemGenotypePulmonary Disease Chronic Obstructive -- microbiologyPrevalenceProspective Studieschemistry.chemical_classificationMESH: AgedCOPDAzole-resistanceMESH: Middle AgedbiologyMESH: Drug Resistance Fungal/geneticsMold environmental exposureSciences bio-médicales et agricolesMiddle Aged3. Good healthMESH: Pulmonary Disease Chronic Obstructive/microbiology*MESH: Housing[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyAir Pollution IndoorAcute DiseaseDisease ProgressionMESH: Acute DiseaseMESH: Cytochrome P-450 Enzyme System/isolation & purificationMESH: Disease ProgressionFemalemedicine.drugmedicine.medical_specialtyEnvironmental EngineeringGenotypeItraconazoleMESH: Fungal Proteins/drug effects030106 microbiologyAspergillus fumigatus -- drug effects -- genetics -- isolation & purificationMESH: Azoles/pharmacology*Fungal Proteins -- drug effects -- isolation & purificationchronic obstructive pulmonary diseaseMicrobiologyFungal Proteins03 medical and health sciencesazole resistanceMESH: Air Pollution Indoor/analysis*Drug Resistance FungalInternal medicinemedicineCOPDHumansMESH: Aspergillus fumigatus/geneticsDwellingMESH: Colony Count MicrobialMESH: PrevalenceAgedAspergillusMESH: HumansAspergillus fumigatusAzoles -- pharmacologyelectrostatic dust collectorPublic Health Environmental and Occupational Healthmold environmental exposureElectrostatic dust collectorBuilding and Constructionmedicine.diseasebiology.organism_classificationMESH: MaleMESH: Prospective StudieschemistryCytochrome P-450 Enzyme System -- drug effects -- isolation & purificationHousingAzoleARAFMESH: Aspergillus fumigatus/isolation & purification*Antifungal Agents -- pharmacologyMESH: Antifungal Agents/pharmacology*MESH: FemaleAir Pollution Indoor -- analysisIndoor air
researchProduct

Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19

2020

Our coalition of public health experts, doctors, and scientists worldwide want to draw attention to the need for high-quality evaluation protocols of the potential beneficial effect of hydroxychloroquine (HCQ) as a post-exposure drug for exposed people. In the absence of an approved, recognized effective pre or post-exposure prophylactic drug or vaccine for COVID-19, nor of any approved and validated therapeutic drug, coupled with social and political pressure raised by publicity both regarding the potential beneficial effect of hydroxychloroquine (HCQ) as well as potential risks from HCQ, we urge the immediate proper clinical trials. Specifically, we mean using HCQ for post-exposure of peo…

Drugmedicine.medical_specialtyPost exposureCoronavirus disease 2019 (COVID-19)COVID19media_common.quotation_subject030231 tropical medicineHydroxychloroquine ; COVID-19 ; Chloroquine ; SARS-CoV2 ; antiviral ; malaria ; Systemic lupus erythematosus ; Immunomodulation ; CoronavirusLoading doseImmunomodulation03 medical and health sciencesSystemic lupus erythematosus0302 clinical medicineChloroquineInternal medicineMedicine030212 general & internal medicineCoronavirus malaria antiviralmedia_commonlcsh:R5-920business.industryStandard treatmentPublic Health Environmental and Occupational HealthChloroquineHydroxychloroquineClinical trialEditorialInfectious DiseasesSARS-CoV2lcsh:Medicine (General)businessHydroxychloroquinemedicine.drugOne Health
researchProduct

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects

2004

The advent of psychotherapeutic drugs has enabled management of mental illness and other neurological problems such as epilepsy in the general population, without requiring hospitalization. The success of these drugs in controlling symptoms has led to their widespread use in the vulnerable population of pregnant women as well, where the potential embryotoxicity of the drugs has to be weighed against the potential problems of the maternal neurological state. This review focuses on the developmental toxicity and neurotoxicity of five broad categories of widely available psychotherapeutic drugs: the neuroleptics, the antiepileptics, the antidepressants, the anxiolytics and mood stabilizers, an…

Drugmedicine.medical_specialtymedia_common.quotation_subjectPopulationDevelopmental toxicityserotonin-reuptake inhibitorsEpilepsyNeurochemicalmedicineAnimalsHumansprenatal phenytoin exposurePsychiatryeducationbeta-adrenergic-receptorsmedia_commonPharmacologyrat-brain developmentPsychotropic Drugseducation.field_of_studybusiness.industryMental DisordersNeurotoxicityBrainbeta-adrenergic-receptors; central-nervous-system; cerebellar granule cells; developing cerebral-cortex; fetal hydantoin syndrome; messenger-rna expression; prenatal phenytoin exposure; rat-brain development; serotonin-reuptake inhibitors; st-johns-wortmedicine.diseaseMental illnessdeveloping cerebral-cortexmessenger-rna expressionMoodcerebellar granule cellsMolecular Medicinecentral-nervous-systemPlant Preparationsst-johns-wortfetal hydantoin syndromebusiness
researchProduct

Assessing the risk to health care staff from long-term exposure to anticancer drugs--the case of monoclonal antibodies.

2010

Today the occupational health and safety risk involved when handling most anticancer drugs is well recognized and, as a result of regulatory requirements, safety measures have been established. There is little knowledge about the occupational hazard posed by handling monoclonal antibodies assigned to ATC Class L01XC. The aim of our study was to evaluate the occupational risk of monoclonal antibodies. Using the information obtained in a systematic review of the literature, the potentially dangerous properties of the active drug substances were assessed using a specially devised algorithm. As a result, all monoclonal antibodies in question were categorized as substances with developmental to…

Drugmedicine.medical_specialtymedicine.drug_classGemtuzumab ozogamicinmedia_common.quotation_subjectMEDLINEAntineoplastic AgentsMonoclonal antibodyRisk AssessmentOccupational safety and healthOccupational ExposureHealth caremedicineAnimalsHumansPharmacology (medical)Intensive care medicineOccupational Healthmedia_commonbusiness.industryAntibodies MonoclonalMolecular WeightOncologyHealth OccupationsImmunologyOccupational exposureRisk assessmentbusinessAlgorithmsmedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct